A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/1998
11/26/1998	WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998	WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998	WO1998052933A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998	WO1998052910A1 Metalloproteinase inhibitors
11/26/1998	WO1998052899A1 Polyhydroxybenzene derivatives and preventive/remedy for bone and cartilage diseases
11/26/1998	WO1998052591A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998	WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998	CA2291169A1 Metalloproteinase inhibitors
11/26/1998	CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998	CA2290426A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998	CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998	CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/26/1998	CA2288327A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/25/1998	EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998	EP0879603A1 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof
11/25/1998	EP0879231A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/25/1998	EP0879227A1 Tyrosin-derivate as alpha-v-integrin inhibitors
11/25/1998	EP0624159B1 Pyridyl substituted imidazoles
11/25/1998	CN1200115A Chiral methyl phenyl oxazolidinones
11/25/1998	CN1199639A Chinese medicine preparation for curing osteonecrosis
11/24/1998	US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors
11/24/1998	US5840837 Coupling protected amino acids, optionally on a resin, deprotecting and purifying polypeptide product
11/22/1998	CA2231017A1 A member of the frzb family, frazzled
11/19/1998	WO1998051678A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
11/19/1998	WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998	WO1998051664A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998	WO1998051662A2 Compounds and methods for the inhibition of the expression of vcam-1
11/19/1998	WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998	WO1998051324A1 Peptide parathyroid hormone analogs
11/19/1998	WO1998051308A1 METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS
11/19/1998	WO1998051307A1 METHODS FOR TREATING INFLAMMATION, INFLAMMATORY DISEASES, ARTHRITIS AND STROKE USING pADPRT INHIBITORS
11/19/1998	WO1998051289A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998	WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998	CA2428130A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998	CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998	CA2290443A1 Peptide parathyroid hormone analogs
11/19/1998	CA2288710A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998	CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/18/1998	EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998	EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998	EP0878467A1 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998	EP0877795A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
11/18/1998	EP0877737A1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity
11/18/1998	EP0877620A1 Peptides for altering osteoblast adhesion
11/18/1998	EP0877601A1 Combination injection preparation
11/18/1998	CN1199340A Analogs of parathyroid hormone
11/18/1998	CN1199045A Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998	CN1198934A Medicated wine for curing rheumarthritis and rheumatoid arthritis and its preparation process
11/17/1998	US5837752 Semi-interpenetrating polymer networks
11/17/1998	US5837674 Administering orally or by injection; oligopeptides
11/17/1998	US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998	CA2101356C Improvements in or relating to benzothiophenes
11/13/1998	CA2237382A1 Substituted 6- and 7-amino-tetrahydroisoquinolinecarboxylic acids
11/13/1998	CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998	WO1998050534A1 Protease inhibitors
11/12/1998	WO1998050533A1 Protease inhibitors
11/12/1998	WO1998050428A1 Treatment of osteoporosis
11/12/1998	WO1998050414A1 B-ring estratriene diol sulphates
11/12/1998	WO1998050413A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
11/12/1998	WO1998050412A1 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring
11/12/1998	WO1998050367A1 Processes and intermediates for preparing substituted indazole derivatives
11/12/1998	WO1998050351A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
11/12/1998	WO1998050342A1 Protease inhibitors
11/12/1998	WO1998050073A1 Integrin ligand, human mindin
11/12/1998	WO1998050054A1 Plant extracts for the treatment of increase bone resorption
11/12/1998	WO1998050032A1 BETA-LACTAM INHIBITORS OF CoA-IT
11/12/1998	WO1998050026A1 Treatment or prevention of menopausal symptoms and osteoporosis
11/12/1998	WO1998032457A3 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/12/1998	DE19719585A1 New N-sulphonyl-di:amino:carboxylic acid derivatives
11/12/1998	CA2289602A1 Protease inhibitors
11/12/1998	CA2289094A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
11/12/1998	CA2289011A1 B-ring estratriene diol sulphates
11/12/1998	CA2289010A1 Protease inhibitors
11/12/1998	CA2289008A1 Estrenes
11/12/1998	CA2288999A1 B-ring estratrienes
11/12/1998	CA2288986A1 Beta-lactam inhibitors of coa-it
11/12/1998	CA2288868A1 Protease inhibitors
11/11/1998	EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998	EP0877019A1 Substituted diaminocarboxylic acid
11/11/1998	EP0877018A1 Sulfonylaminocarboxylic acids
11/11/1998	EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998	EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998	EP0876345A1 Heterocyclic compounds as h+-atpases
11/11/1998	EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998	CN1198775A Recombinant c-proteinase and processes, methods and uses thereof
11/11/1998	CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998	CN1198668A Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
11/11/1998	CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis
11/11/1998	CN1198339A Wine for curing bone impediment and rheumatic pain
11/11/1998	CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998	US5834508 Ketone derivatives
11/10/1998	US5834188 For inducing human osteogenic protein 1
11/10/1998	US5833954 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices
11/09/1998	CA2237052A1 Substituted diaminocarboxylic acids
11/07/1998	CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998	WO1998049319A1 Human lysophospholipase
11/05/1998	WO1998049296A1 Human cerberus protein
11/05/1998	WO1998049169A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998	WO1998049152A1 Protease inhibitors
11/05/1998	WO1998049138A2 Vitamin d3 analogs with bis c-20 side chains

1 ... 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 ... 820